JESSICA PENATE: Open Payments
NPI 1528848470 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,444 in 136 payments from 12 companies in 2025. Trend: 2023 $21 · 2024 $586 · 2025 $3,444
Food & beverage: $3,444
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $641 |
| Vanda Pharmaceuticals Inc. | 14 | $483 |
| Alkermes, Inc. | 13 | $382 |
| Otsuka America Pharmaceutical, Inc. | 13 | $374 |
| Corium, LLC | 13 | $330 |
| Lundbeck LLC | 11 | $314 |
| Axsome Therapeutics, Inc. | 10 | $296 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $272 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $165 |
| Collegium Pharmaceutical, Inc. | 4 | $81 |
Products named: VRAYLAR, REXULTI, Azstarys, FANAPT, Auvelity, CAPLYTA, ARISTADA, HETLIOZ.
Industry payments across FL — which companies pay providers there.
